This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Shionogi Company Limited, Institute of Medicinal Molecular Design, Inc.. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2012)
- Toyonaka, JP (2019 - 2020)
Company Filing History:

Years Active: 2012-2020
Title: Takafumi Ohara: Innovator in Antifungal Compounds
Introduction
Takafumi Ohara is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antifungal compounds. With a total of 3 patents to his name, Ohara's work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Ohara's latest patents include a Polyene macrolide derivative, specifically an Amphotericin B derivative. This invention details a compound where the 16th position (X) can be a urea structure, cyclic structure, hydroxyalkyl, or substituted monoalkylcarbamoyl. The compound exhibits antifungal activity, showcasing its potential for therapeutic applications.
Career Highlights
Throughout his career, Takafumi Ohara has worked with reputable organizations, including Shionogi Company Limited and the Institute of Medicinal Molecular Design, Inc. His experience in these companies has allowed him to refine his expertise in medicinal chemistry and contribute to innovative solutions in the field.
Collaborations
Ohara has collaborated with notable colleagues such as Keisuke Miyazaki and Kenji Takaya. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
In summary, Takafumi Ohara is a distinguished inventor whose work in antifungal compounds has garnered attention in the pharmaceutical industry. His innovative contributions continue to pave the way for advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile